CClinicalTrials.gg
CompletedNCT02934087EVARUpdated Oct 14, 2016

Endovascular Aneurysm Repair (EVAR) Gate Study

An interventional study of Endovascular Aneurysm Repair in Abdominal Aortic Aneurysm (AAA), sponsored by Minneapolis Heart Institute Foundation. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2016-10-14.

Sponsored by Minneapolis Heart Institute Foundation · Not applicable and Interventional

Phase
Not applicable
Study type
Interventional
Enrollment
102
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study will evaluate a randomized comparison of direct versus snare techniques for cannulation of contralateral gate during an endovascular aneurysm repair (EVAR) procedure.

This information will be used to determine if primary snaring is superior to retrograde cannulation in decreasing procedural time and radiation exposure.

Read the detailed description

Endografts currently FDA-approved for abdominal aortic aneurysm (AAA) repair are modular systems,comprised of a main body (Aortic Trunk) and two legs (Ipsilateral Leg Endoprosthesis and a contralateral leg endoprosthesis). In placement of the endograft the main body and ipsilateral limb are deployed from a retrograde common femoral artery approach. From the contralateral femoral artery, cannulation of the contralateral gate is required to deploy the contralateral iliac limb.Cannulation of the contralateral limb gate is the portion of the operation that requires the most "wire skills." Depending on the patients' body type, angulations of the aorta and the size and volume of the AAA, this portion of the procedure can be technically difficult. This portion may become lengthy and discouraging if the surgeon fails to cannulate the gate using a particular approach. Cannulation of the contralateral limb gate from a retrograde femoral artery approach is commonly achieved by first using a maneuverable guidewire and steerable catheter. Antegrade or crossover cannulation involves passing a guidewire from the ipsilateral limb to the contralateral limb gate of the endograft, which can be accomplished with a curved catheter. The wire may be retrieved on the contralateral limb using a snare device. The problem and why it is important -- difficulty in accessing the contralateral gate leads to increase procedural time and excess exposure to radiation. The standard of care is retrograde cannulation with the use of crossover snare techniques as a secondary adjunct if retrograde cannulation fails. In this study we will compare retrograde cannulation to primary snaring.

02

Conditions studied

  • Abdominal Aortic Aneurysm (AAA)

Keywords

  • snare technique
  • cannulation of contralateral gate
  • endovascular
  • aneurysm
  • AAA
  • Abdominal Aortic Aneurysm
03

In context

Aneurysm

960 studies on the registry are indexed under Aneurysm; 174 are open to participants now.

This study's enrollment of 102 is above the median of 72 across 461 interventional studies indexed under Aneurysm.

Browse Aneurysm studies →

Lead sponsor

Minneapolis Heart Institute Foundation is the lead sponsor of 33 studies on the registry; 13 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Age ≥ 18
  • Patient is undergoing EVAR repair with a commercially available endograft
  • Willing to give consent
  • Procedure is Elective

Exclusion criteria

Exclusion Criteria:

  • Declines to participate
  • Unable to provide consent
  • Urgent AAA repair
  • Participating in another study
05

Study design

Phase
Not applicable
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
102 participants (actual)

Study arms

  • Active comparator
    Retrograde Gate Cannulation

    All patients undergoing elective EVAR with a standard commercially available stent graft will be randomized after informed consent obtained; gate cannulation method will be attempted for a period of 15 minutes. If unsuccessful during this time a crossover to the alternative method (snare) will be attempted. The study will be terminated at 15 minutes in the crossover arm if still unsuccessful.

    Procedure: Endovascular Aneurysm Repair

  • Active comparator
    Snare Technique

    All patients undergoing elective EVAR with a standard commercially available stent graft were randomized after informed consent obtained; gate cannulation method was attempted for a period of 15 minutes. If unsuccessful during this time a crossover to the alternative method (retrograde gate cannulation) was attempted. The study will be terminated at 15 minutes in the crossover arm if still unsuccessful. Antegrade or crossover cannulation involves passing a guidewire from the ipsilateral limb to the contralateral limb gate of the endograft, which can be accomplished with a curved catheter. The wire may be retrieved on the contralateral limb using a snare device.

    Procedure: Endovascular Aneurysm Repair

Interventions

  • ProcedureEndovascular Aneurysm Repair

    Endovascular aneurysm repair (or endovascular aortic repair) (EVAR) is a type of endovascular surgery used to treat pathology of the aorta, most commonly an abdominal aortic aneurysm (AAA)

    Also known as: EVAR

06

What researchers measure

Primary outcomes

  1. Primary Endpoint: Time to contralateral gate cannulation

    The patient will be randomized to either a snare or retrograde technique in a 1:1 ratio intraoperatively at the time of deployment of the main body of the graft. The timer will be started at 0 when positioning catheter is withdrawn from para-renal position into sac. The timer will be stopped after successful gate cannulation or after 30 minutes of fluoroscopy time.

    Time frame: Intra-operatively comparing the time to contralateral gate cannulation (snare or retrograde techniques) .

07

Study locations

1 site
  • Minneapolis Heart Institute
    Minneapolis, Minnesota 55407, United States
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 14, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02934087
Lead sponsor
Minneapolis Heart Institute Foundation
Responsible party
Sponsor
First posted
Oct 14, 2016
Start date
Aug 2011
Primary completion
Mar 2014
Completion
Mar 2014
Last update
Oct 14, 2016

Study contacts

Jessica Titus, MD
principal investigator · Minneapolis Heart Institute Foundation

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion